The 23 studies that the #FDA based its expanded #leucovorin label on.
The science supports it for a rare disorder with “autism-like’”symptoms.
The sole paper linking it to autism was retracted in January.
“Leucovorin prescriptions for children with autism increased by 71 percent after a White House briefing last September that promoted the drug as an #autism treatment.”







